Literature DB >> 15324307

UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulation.

Florence Fassy1, Odile Krebs, Maryse Lowinski, Paul Ferrari, Jacques Winter, Véronique Collard-Dutilleul, Khadidja Salahbey Hocini.   

Abstract

UMP kinase catalyses the phosphorylation of UMP by ATP to yield UDP and ADP. In prokaryotes, the reaction is carried out by a hexameric enzyme, activated by GTP and inhibited by UTP. In the present study, Streptococcus pneumoniae UMP kinase was studied as a target for antibacterial research and its interest was confirmed by the demonstration of the essentiality of the gene for cell growth. In the presence of MnCl2 or MgCl2, the saturation kinetics of recombinant purified UMP kinase was hyperbolic for UMP (K(m)=0.1 mM) and sigmoidal for ATP (the substrate concentration at half-saturation S0.5=9.4+/-0.7 mM and n=1.9+/-0.1 in the presence of MgCl2). GTP increased the affinity for ATP and decreased the Hill coefficient (n). UTP decreased the affinity for ATP and only slightly increased the Hill coefficient. The kcat (175+/-13 s(-1) in the presence of MgCl2) was not affected by the addition of GTP or UTP, whose binding site was shown to be different from the active site. The hydrodynamic radius of the protein similarly decreased in the presence of ATP or GTP. There was a shift in the pH dependence of the activity when the ATP concentration was switched from low to high. These results support the hypothesis of an allosteric transition from a conformation with low affinity for ATP to a form with high affinity, which would be induced by the presence of ATP or GTP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324307      PMCID: PMC1134148          DOI: 10.1042/BJ20040440

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Structural properties of UMP-kinase from Escherichia coli: modulation of protein solubility by pH and UTP.

Authors:  L Serina; N Bucurenci; A M Gilles; W K Surewicz; H Fabian; H H Mantsch; M Takahashi; I Petrescu; G Batelier; O Bârzu
Journal:  Biochemistry       Date:  1996-06-04       Impact factor: 3.162

2.  Structural and catalytic properties of CMP kinase from Bacillus subtilis: a comparative analysis with the homologous enzyme from Escherichia coli.

Authors:  C P Schultz; L Ylisastigui-Pons; L Serina; H Sakamoto; H H Mantsch; J Neuhard; O Bârzu; A M Gilles
Journal:  Arch Biochem Biophys       Date:  1997-04-01       Impact factor: 4.013

3.  X-ray scattering titration of the quaternary structure transition of aspartate transcarbamylase with a bisubstrate analogue: influence of nucleotide effectors.

Authors:  L Fetler; P Tauc; G Hervé; M F Moody; P Vachette
Journal:  J Mol Biol       Date:  1995-08-11       Impact factor: 5.469

4.  The Bacillus subtilis chromosome region encoding homologues of the Escherichia coli mssA and rpsA gene products.

Authors:  A Sorokin; P Serror; P Pujic; V Azevedo; S D Ehrlich
Journal:  Microbiology       Date:  1995-02       Impact factor: 2.777

5.  Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP.

Authors:  L Serina; C Blondin; E Krin; O Sismeiro; A Danchin; H Sakamoto; A M Gilles; O Bârzu
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

6.  Three highly homologous membrane-bound lipoproteins participate in oligopeptide transport by the Ami system of the gram-positive Streptococcus pneumoniae.

Authors:  G Alloing; P de Philip; J P Claverys
Journal:  J Mol Biol       Date:  1994-08-05       Impact factor: 5.469

7.  CMP kinase from Escherichia coli is structurally related to other nucleoside monophosphate kinases.

Authors:  N Bucurenci; H Sakamoto; P Briozzo; N Palibroda; L Serina; R S Sarfati; G Labesse; G Briand; A Danchin; O Bărzu; A M Gilles
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

8.  Movie of the structural changes during a catalytic cycle of nucleoside monophosphate kinases.

Authors:  C Vonrhein; G J Schlauderer; G E Schulz
Journal:  Structure       Date:  1995-05-15       Impact factor: 5.006

9.  High cell density cultivation of Escherichia coli at controlled specific growth rate.

Authors:  D Riesenberg; V Schulz; W A Knorre; H D Pohl; D Korz; E A Sanders; A Ross; W D Deckwer
Journal:  J Biotechnol       Date:  1991-08       Impact factor: 3.307

10.  Identification and characterization of the smbA gene, a suppressor of the mukB null mutant of Escherichia coli.

Authors:  K Yamanaka; T Ogura; H Niki; S Hiraga
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

View more
  4 in total

1.  Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein-protein interaction network.

Authors:  Siqi Li; Zhipeng Su; Chengjun Zhang; Zhuofei Xu; Xiaoping Chang; Jiawen Zhu; Ran Xiao; Lu Li; Rui Zhou
Journal:  Genes Genomics       Date:  2018-05-03       Impact factor: 1.839

2.  Potential therapeutic drug target identification in Community Acquired-Methicillin Resistant Staphylococcus aureus (CA-MRSA) using computational analysis.

Authors:  Pramod Kumar Yadav; Gurmit Singh; Satendra Singh; Budhayash Gautam; Esmaiel If Saad
Journal:  Bioinformation       Date:  2012-07-21

3.  Structural and functional characterization of the Mycobacterium tuberculosis uridine monophosphate kinase: insights into the allosteric regulation.

Authors:  Gilles Labesse; Khaled Benkali; Isabelle Salard-Arnaud; Anne-Marie Gilles; Hélène Munier-Lehmann
Journal:  Nucleic Acids Res       Date:  2010-12-10       Impact factor: 16.971

4.  Rv2629 Overexpression Delays Mycobacterium smegmatis and Mycobacteria tuberculosis Entry into Log-Phase and Increases Pathogenicity of Mycobacterium smegmatis in Mice.

Authors:  Dan Liu; Kewei Hao; Wenjie Wang; Chao Peng; Yue Dai; Ruiliang Jin; Wenxi Xu; Lei He; Hongyan Wang; Honghai Wang; Lu Zhang; Qingzhong Wang
Journal:  Front Microbiol       Date:  2017-11-15       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.